Concerns concerning this dynamic have led some drug-policy scholars to search for alternate approaches. Beau Kilmer, a co-director of RAND’S Drug Coverage Study Centre, has with his colleagues tried to determine a spectrum of choices amongst prohibition (punishing individuals for marketing or possessing a drug) and commercialization (permitting businesses https://pearlx850nvs1.webbuzzfeed.com/profile